Pharmaceuticals (648) | Bonus & Incentive Agreements (648)

Browse by Company

Acasti Pharma Inc. (1)
ACELRX PHARMACEUTICALS INC (6)
Acer Therapeutics Inc. (4)
Aclaris Therapeutics, Inc. (2)
Acreage Holdings, Inc. (2)
Adamis Pharmaceuticals Corp (3)
ADIAL PHARMACEUTICALS, INC. (1)
AERIE PHARMACEUTICALS INC (1)
Aerpio Pharmaceuticals, Inc. (4)
Akers Biosciences, Inc. (3)
ALIMERA SCIENCES INC (6)
Amag Pharmaceuticals (8)
Amneal Pharmaceuticals, Inc. (3)
Ampio Pharmaceuticals, Inc. (2)
Amylyx Pharmaceuticals, Inc. (3)
AN2 Therapeutics, Inc. (5)
Anebulo Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (8)
ANI Pharma Inc (3)
ARVINAS, INC. (2)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (2)
ATAI Life Sciences B.V. (6)
Atea Pharmaceuticals, Inc. (4)
Athira Pharma, Inc. (8)
AVADEL PHARMACEUTICALS PLC (2)
Axsome Therapeutics, Inc. (2)
Bakhu Holdings, Corp. (1)
Baudax Bio, Inc. (2)
Bausch Health Companies Inc. (6)
Bespoke Extracts, Inc. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (5)
Biofrontera Inc. (4)
BioPharmX Corp (2)
Blue Water Acquisition Corp. (2)
Bristol-Myers Squibb (48)
Cannabics Pharmaceuticals Inc. (1)
Canopy Growth Corp (8)
CASSAVA SCIENCES INC (1)
Catalent Inc (7)
Cerecor Inc. (2)
CHINA PHARMA HOLDINGS, INC. (1)
CinCor Pharma, Inc. (1)
Cingulate Inc. (3)
Clever Leaves Holdings Inc. (5)
COGNITION THERAPEUTICS INC (6)
COLLEGIUM PHARMACEUTICAL, INC (1)
Columbia Care Inc. (1)
Context Therapeutics Inc. (3)
Corcept Therapeutics Incorporated (1)
CorMedix Inc. (3)
COSMO VENTURES INC (1)
Cronos Group Inc. (3)
CUMBERLAND PHARMACEUTICALS INC (2)
Cure Pharmaceutical Holding Corp. (4)
Cyteir Therapeutics, Inc. (9)
Dermata Therapeutics, Inc. (4)
DiCE MOLECULES HOLDINGS, LLC (2)
Edgewise Therapeutics, Inc. (3)
Elanco Animal Health Inc (7)
Endo International plc (13)
Eton Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (4)
Evolus, Inc. (1)
Exactus, Inc. (5)
EYEGATE PHARMACEUTICALS INC (1)
EYENOVIA, INC. (4)
EyePoint Pharmaceuticals, Inc. (3)
Fulcrum Therapeutics, Inc. (10)
GRAYBUG VISION, INC. (3)
Green Thumb Industries Inc. (2)
GW PHARMACEUTICALS PLC (2)
Harmony Biosciences Holdings, Inc. (5)
Horizon Pharma plc (6)
Ikena Oncology, Inc. (2)
IMARA Inc. (9)
INNOVATE BIOPHARMACEUTICALS, INC. (3)
Intersect ENT, Inc. (2)
Intra-Cellular Therapies, Inc. (5)
Jaguar Health, Inc. (1)
Jazz Pharmaceuticals plc (16)
Kala Pharmaceuticals, Inc. (3)
Kaleido Biosciences, Inc. (3)
Kannalife Inc (2)
KEMPHARM, INC (2)
Landos Biopharma, Inc. (1)
Lexaria Bioscience Corp. (1)
Lilly (Eli) & Co. (10)
Liquidia Corp (3)
Longboard Pharmaceuticals, Inc. (6)
Lyra Therapeutics, Inc. (5)
Mallinckrodt (2)
MARINUS PHARMACEUTICALS INC (10)
Medicine Man Technologies, Inc. (4)
MedMen Enterprises, Inc. (1)
Menlo Therapeutics Inc. (6)
Merck (4)
Milestone Pharmaceuticals Inc. (5)
Mind Medicine (MindMed) Inc. (2)
Mylan N.V. (5)
Nabriva Therapeutics plc (10)
NEKTAR THERAPEUTICS (3)
Neuralstem, Inc. (9)
NGM BIOPHARMACEUTICALS INC (3)
NovaBay Pharmaceuticals, Inc. (3)
Novan, Inc. (4)
OCULAR THERAPEUTIX, INC (4)
OMEROS CORP (2)
Onconova Therapeutics, Inc. (1)
One World Pharma, Inc. (3)
OPIANT PHARMACEUTICALS, INC. (2)
OptiNose, Inc. (1)
Organon & Co. (3)
Osmotica Pharmaceuticals plc (6)
Pacira Pharmaceuticals, Inc. (6)
Panacea Acquisition Corp (6)
Perrigo (15)
Petros Pharmaceuticals, Inc. (2)
Pfizer (1)
Phathom Pharmaceuticals, Inc. (9)
PLIANT THERAPEUTICS, INC. (3)
Processa Pharmaceuticals, Inc. (2)
Pulmatrix, Inc. (1)
QUANTA INC (1)
Rain Therapeutics Inc. (1)
Rani Therapeutics Holdings, Inc. (3)
REATA PHARMACEUTICALS INC (1)
Recro Pharma, Inc. (1)
RELMADA THERAPEUTICS, INC. (5)
RespireRx Pharmaceuticals Inc. (8)
resTORbio, Inc. (15)
Revance Therapeutics, Inc. (5)
Roivant Sciences Ltd. (3)
Royalty Pharma plc (2)
Satsuma Pharmaceuticals, Inc. (7)
Scopus BioPharma Inc. (2)
SCYNEXIS INC (1)
SenesTech, Inc. (2)
Sienna Biopharmaceuticals, Inc. (4)
Supernus Pharmaceuticals, Inc. (6)
Tarsus Pharmaceuticals, Inc. (2)
Tenzing Acquisition Corp. (4)
Terns Pharmaceuticals, Inc. (8)
Terra Tech Corp. (5)
TEVA PHARMACEUTICAL INDUSTRIES LTD (4)
TFF Pharmaceuticals, Inc. (1)
TherapeuticsMD, Inc. (1)
Theseus Pharmaceuticals, Inc. (2)
TITAN PHARMACEUTICALS INC (1)
Trevi Therapeutics, Inc. (4)
Tricida, Inc. (1)
Trulieve Cannabis Corp. (1)
Upjohn Inc (7)
Urovant Sciences Ltd. (2)
Vallon Pharmaceuticals, Inc. (4)
Ventyx Biosciences, Inc. (4)
Virpax Pharmaceuticals, Inc. (4)
Vitality Biopharma, Inc. (1)
Wave Life Sciences Ltd. (5)
ZOGENIX, INC. (4)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

9 Meters Biopharma, Inc. 2022 Stock Incentive Plan (INNOVATE BIOPHARMACEUTICALS, INC., Filed With SEC on June 22, 2022)
Amendment to 2020 Long-Term Incentive Plan (Liquidia Corp, Filed With SEC on June 17, 2022)
Eyenovia, Inc. Amended and Restated 2018 Omnibus Stock Incentive Plan (EYENOVIA, INC., Filed With SEC on June 17, 2022)
Relmada Therapeutics, Inc. 2021 Equity Incentive Plan, as amended (RELMADA THERAPEUTICS, INC., Filed With SEC on June 1, 2022)
Canopy Growth Corporation Amended and Restated Omnibus Incentive Plan (Canopy Growth Corp, Filed With SEC on May 31, 2022)
Form of Award Agreement Awarding Restricted Stock Units under the Novan, Inc. 2016 Incentive Award Plan (Novan, Inc., Filed With SEC on May 16, 2022)
Description of unwritten cash bonus plan adopted June 14, 2021 (Medicine Man Technologies, Inc., Filed With SEC on May 16, 2022)
Form of Incentive Stock Option Award under 2021 Plan (Cingulate Inc., Filed With SEC on May 12, 2022)
Forms of Option Grant Notice and Option Agreement under the 2021 Equity Incentive Plan Long-Term Incentive Program (Panacea Acquisition Corp, Filed With SEC on May 9, 2022)
Form of Restricted Stock Unit Agreement under 2018 Stock Incentive Plan (ARVINAS, INC., Filed With SEC on May 5, 2022)